Elekta AB (SE:EKTAB) and Key Distributor Enter Agreement to Increase Production Efforts of Radiotherapy Technology in Russia  
10/29/2012 6:38:44 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta, (STO:EKTAB) a world leader in the design and manufacture of cancer treatment technology and software, and MSM-MEDIMPEX, a major Russian medical technology distributor, have announced their intention to set up production of radiotherapy equipment in Russia, with the intent to improve access to radiation therapy treatments to Russian citizens afflicted with cancer. Russia is the world’s ninth most populous country.